Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg “All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)”

key information

study id #: NCT03555578

condition: Spinal and Bulbar Muscular Atrophy

status: Recruiting


The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.

intervention: Leuprorelin Acetate


last updated: February 04, 2022